Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

227 ARTÍCULOS , VIENDO DEL 31 AL 45

Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects

Gessain A, Mahieux R.

Rev Neurol (Paris). 2012 Mar;168(3):257-69. doi: 10.1016/j.neurol.2011.12.006. Epub 2012 Mar 7.

Botulinum toxin A in prostate disease: a venom from bench to bed-side

Mearini L, Giannantoni A.

Curr Drug Deliv. 2012 Jan;9(1):85-94. doi: 10.2174/156720112798375970.

Recognition and diagnosis of neuro-ichthyotic syndromes

Rizzo WB, Jenkens SM, Boucher P.

Semin Neurol. 2012 Feb;32(1):75-84. doi: 10.1055/s-0032-1306390. Epub 2012 Mar 15.

Neural tension technique is no different from random passive movements in reducing spasticity in patients with traumatic brain injury

Lorentzen J, Nielsen D, Holm K, Baagøe S, Grey MJ, Nielsen JB.

Disabil Rehabil. 2012;34(23):1978-85. doi: 10.3109/09638288.2012.665132. Epub 2012 Mar 19.

Botulinum toxin type A for the treatment of equinus deformity in patients with mucopolysaccharidosis type II

Nava E, Weber P, Gautschi M, Nuoffer JM, Grunt S.

J Child Neurol. 2012 Dec;27(12):1611-5. doi: 10.1177/0883073812438100. Epub 2012 Mar 20.

Evidence to practice: botulinum toxin in the treatment of spasticity post stroke

Teasell R, Foley N, Pereira S, Sequeira K, Miller T.

Top Stroke Rehabil. 2012 Mar-Apr;19(2):115-21. doi: 10.1310/tsr1902-115.

Contribution of ankle dorsiflexor strength to walking endurance in people with spastic hemiplegia after stroke

Ng SS, Hui-Chan CW.

Arch Phys Med Rehabil. 2012 Jun;93(6):1046-51. doi: 10.1016/j.apmr.2011.12.016. Epub 2012 Mar 20.

Effect of topical anesthetics on needle insertion pain during botulinum toxin type A injections for limb spasticity

Fung S, Phadke CP, Kam A, Ismail F, Boulias C.

Arch Phys Med Rehabil. 2012 Sep;93(9):1643-7. doi: 10.1016/j.apmr.2012.03.012. Epub 2012 Mar 23.

Extract from Cannabis sativa -- Benefit Assessment According to §35a Social Code Book V

Institute for Quality and Efficiency in Health Care.

Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2012 Mar 29. Extract of Dossier Assessment No. A12-01.

Gastrointestinal involvement in spinal cord injury: a clinical perspective

Ebert E.

J Gastrointestin Liver Dis. 2012 Mar;21(1):75-82.

The biology that underpins the therapeutic potential of cannabis-based medicines for the control of spasticity in multiple sclerosis

Baker D, Pryce G, Jackson SJ, Bolton C, Giovannoni G.

Mult Scler Relat Disord. 2012 Apr;1(2):64-75. doi: 10.1016/j.msard.2011.11.001. Epub 2012 Jan 18.

Spinal arachnoid cysts in the pediatric population: report of 31 cases and a review of the literature

Bond AE, Zada G, Bowen I, McComb JG, Krieger MD.

J Neurosurg Pediatr. 2012 Apr;9(4):432-41. doi: 10.3171/2012.1.PEDS11391.

Intravitreal ranibizumab injection for choroidal neovascularization in Strümpell-Lorrain Syndrome

Tran TH, Baglin G, Querques G.

J Fr Ophtalmol. 2012 May;35(5):353-5. doi: 10.1016/j.jfo.2011.12.004. Epub 2012 Mar 30.

Neuromodulation of lower limb motor control in restorative neurology

Minassian K, Hofstoetter U, Tansey K, Mayr W.

Clin Neurol Neurosurg. 2012 Jun;114(5):489-97. doi: 10.1016/j.clineuro.2012.03.013. Epub 2012 Mar 29.

Patient registry of outcomes in spasticity care

Esquenazi A, Mayer N, Lee S, Brashear A, Elovic E, Francisco GE, Yablon S; PROS Study Group.

Am J Phys Med Rehabil. 2012 Sep;91(9):729-46. doi: 10.1097/PHM.0b013e31824fa9ca.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias